Stem cell therapies in patients with single ventricle physiology.

Abstract

Single ventricle physiology, especially hypoplastic left heart syndrome, is one of the most high-risk lesions in children with congenital heart disease, and the ensuing heart failure remains as a major problem related to adverse outcomes in these patients. The field of stem cell therapy for heart failure has shown striking advances during the past 10 years, and many clinical trials using stem cell technologies have been conducted in adults, which suggest that stem cell therapy is associated with long-term improvement in cardiac function. Cardiac progenitor cells have recently been discovered, and their strong regenerative ability has been demonstrated in several studies. Although no large clinical trials have been performed in the field of congenital heart disease, recent investigations indicate that stem cell therapy may hold great potential to treat children with cardiac defects.

• Authors: Suguru Tarui, Shunji Sano, Hidemasa Oh
• Journal: Methodist DeBakey cardiovascular journal (Methodist Debakey Cardiovasc J) 2014 Apr-Jun Vol. 10 Issue 2 Pg. 77-81 ISSN: 1947-6108 [Electronic] United States
• PMID: 25114758 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Topics

• Animals
• Heart Ventricles (abnormalities, physiopathology, surgery)
• Humans
• Hypoplastic Left Heart Syndrome (diagnosis, physiopathology, surgery)
• Recovery of Function
• Regeneration
• Regenerative Medicine (methods)
• Stem Cell Transplantation
• Treatment Outcome
• Ventricular Function, Left